The cAMP pathway was already found to be associated with cancer, with the overexpression of ADCY3 increasing oncogenic potential in gastric cancer cells [15] and ADCY8 acting itself as a risk modifier in glioma [16]. Here, ADCY3 is linked to central nervous system cancer.